cysteine has been researched along with HIV Coinfection in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (3.70) | 18.7374 |
1990's | 24 (44.44) | 18.2507 |
2000's | 12 (22.22) | 29.6817 |
2010's | 12 (22.22) | 24.3611 |
2020's | 4 (7.41) | 2.80 |
Authors | Studies |
---|---|
Aldrovandi, GM; Clark, JL; D'Aquila, R; Elliott, J; Fulcher, JA; Gorbach, PM; Kipke, MD; Li, F; Mustanski, B; Shoptaw, S; Tobin, NH; Zabih, S | 1 |
Ha, MW; Hong, JC; Jung, TS; Kumar, V; Lee, G; Lee, KW; Singh, P | 1 |
Adiga, V; Ahuja, VK; Bandyopadhyay, P; Kohli, S; Malhotra, N; Mehta, M; Mishra, R; Munshi, M; Rajmani, RS; Seshasayee, ASN; Shandil, RK; Singh, A | 1 |
Datta, R; Hanna, LE; Manjunath, K; Roy Chowdhury, R; Varadarajan, R | 1 |
Albertolle, M; Deal, A; Doulias, PT; Ischiropoulos, H; Lipton, SA; McKercher, SR; Nakamura, T; Scott, H; Sultan, A | 1 |
Borges-Santos, MD; Burini, RC; Moreto, F; Yu, YM | 1 |
Alexander, DL; Berman, PW; Deeks, SG; Hutchinson, JM; Limoli, KL; Mesa, KA; O'Rourke, SM; Wrin, T; Yu, B | 1 |
Back, DJ; Earnshaw, CJ; French, NS; Howarth, A; Jenkins, RE; Meng, X; Naisbitt, DJ; Park, BK | 1 |
Hsu, JW; Jahoor, F; Nguyen, D; Sekhar, RV | 1 |
Brown, LA; Cribbs, SK; Guidot, DM; Lennox, J; Martin, GS | 1 |
Balzarini, J; Mathys, L | 1 |
Liu, CW; Rice, S; Sekhar, RV | 1 |
Amogne, W; Caulk, AW; Evans, D; Gleason, RL; Keegan, PM; McNamara, L; Parker, IK; Penny, C; Platt, MO; Roberts, LM; Seifu, D | 1 |
Bebbington, J; Center, RJ; Cuthbertson, J; Gonelli, C; Heydarchi, B; Khoury, G; Lichtfuss, M; Mackenzie, C; Muller, B; Purcell, D; Rawlin, G | 1 |
Ashkenazi, A; Merklinger, E; Shai, Y | 1 |
Bhrigu, V; Bisen, PS; Jain, A; Khan, Z; Kumar, P; Tiwari, RP | 1 |
Foster, HD | 1 |
Bramanti, E; Paladini, A; Raspi, G; Sbrana, E; Spinetti, MC | 1 |
Bajad, S; Beckwith, MD; Bellehumeur, JL; Graziano, FM; Trepanier, LA; Yoder, AR | 1 |
Pulliam, L; Rempel, HC | 1 |
Abdalla, DS; Ferreira, SI; Luis, MC; Masokawa, IY; Reis, M; Spada, C; Treitinger, A; Van Der Sander Silveira, M; Verdi, JC | 1 |
Bianchi, E; Carella, AV; Finotto, M; Geleziunas, R; Hou, XS; Hrin, R; Ingallinella, P; Miller, MD; Pessi, A; Schleif, WA | 1 |
Boykins, RA; Clouse, KA; Devadas, K; Dhawan, S; Hardegen, NJ; Hewlett, IK; Kleinman, HK; Osa, EO; Philp, D; Rappaport, J; Wahl, LM; Wang, J; Yamada, KM | 1 |
Atkuri, KR; Herzenberg, LA; Mantovani, JJ | 1 |
Dröge, W; Galter, D; Mihm, S | 1 |
Aukrust, P; Berge, RK; Frøland, SS; Lunden, B; Müller, F; Svardal, AM; Ueland, PM | 1 |
Dröge, W; Eck, HP; Fischbach, T; Hartung, S; Kinscherf, R; Murthy, KK; Peterhans, E; Plesker, R; Rouse, S; Stahl-Hennig, C | 1 |
Dröge, W; Eck, HP; Mihm, S | 2 |
Dröge, W; Eck, HP; Fischbach, T; Kinscherf, R; Mihm, S; Roth, S | 1 |
Akerlund, B; Jarstrand, C | 1 |
Aukrust, P; Berge, RK; Frøland, SS; Müller, F; Svardal, AM; Ueland, PM | 1 |
Helbling, B; Lauterburg, BH; von Overbeck, J | 1 |
Essex, M; Lee, TH; Mayer, KH; Wang, WK | 1 |
Akerblad, AC; Akerlund, B; Jarstrand, C; Lindeke, B; Rasool, O; Sönnerborg, A | 1 |
Bockstette, M; Dröge, W; Galter, D; Gross, A; Hack, V; Kinscherf, R; Mihm, S; Schykowski, M | 1 |
Blair, DC; Holohan, PD; Lehmann, DF | 1 |
Harrison, ML; Uetrecht, JP; Walmsley, SL; Wells, PG; Winn, LM | 1 |
Barditch-Crovo, P; Borum, P; Buier, R; Goldberg, D; Kalayjian, RC; Lederman, M; Lietman, P; Noe, D; Rowe, WB; Skowron, G | 1 |
Ge, YC; Jozwiak, R; Saksena, NK; Wang, B | 1 |
Breitkreutz, R; Dröge, W; Galter, D; Hack, V; Holm, E; Schmid, E; Shubinsky, G | 1 |
Aoki, M; Genka, I; Kikuchi, Y; Oka, S; Tachikawa, N; Teruya, K; Yamaguchi, M; Yamamoto, Y; Yasuoka, A; Yasuoka, C | 1 |
Breitkreutz, R; Dröge, W | 1 |
Naisbitt, DJ; Park, BK; Pirmohamed, M; Stalford, AC; Vilar, FJ; Wilkins, EG | 1 |
Boucher, CA; de Jong, MD; Lange, JM; Schuurman, R | 1 |
Huang, A; Lang, CA; Liu, MC; Ramirez, JA | 1 |
Allen, RH; Berthold, HK; Look, MP; Riezler, R; Rockstroh, JK; Sauerbruch, T; Schliefer, K; Stabler, SP | 1 |
de Quay, B; Lauterburg, BH; Malinverni, R | 1 |
Baker, DH; Wood, RJ | 1 |
Agy, MB; Coombs, RW; Corey, L; Frumkin, LR; Katze, MG; Koehler, J; Morton, WR; Wolinsky, SM | 1 |
Dröge, W; Eck, HP; Gmünder, H; Mihm, S | 1 |
Dröge, W; Eck, HP; Frey, H | 1 |
Houghten, RA; Lerner, RA; Norrby, E; Parks, DE; Utter, G | 1 |
8 review(s) available for cysteine and HIV Coinfection
Article | Year |
---|---|
N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency.
Topics: Acetaminophen; Acetylcysteine; Antidotes; Controlled Clinical Trials as Topic; Cysteine; Cystic Fibrosis; Free Radical Scavengers; Glutathione; HIV Infections; Humans; Prodrugs; Quality of Life | 2007 |
Oxygen radical release by neutrophils of HIV-infected patients.
Topics: Acetylcysteine; Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Cysteine; Female; Free Radicals; HIV Infections; Humans; Male; Neutrophils; Oxidation-Reduction; Randomized Controlled Trials as Topic; Superoxides | 1994 |
Role of cysteine and glutathione in HIV infection and cancer cachexia: therapeutic intervention with N-acetylcysteine.
Topics: Acetylcysteine; Amino Acids; Cachexia; Cysteine; Glutathione; HIV Infections; Humans; Muscle, Skeletal; Neoplasms | 1997 |
Role of cysteine and glutathione in signal transduction, immunopathology and cachexia.
Topics: Animals; Cachexia; Cysteine; Cystine; Disease Progression; Glutathione; HIV Infections; Humans; Killer Cells, Natural; Muscle, Skeletal; Muscular Diseases; Signal Transduction | 1998 |
Glutathione and immune function.
Topics: Acetylcysteine; Cysteine; Glutathione; HIV Infections; Humans; Immunity; Lymphocytes | 2000 |
HIV-induced cysteine deficiency and T-cell dysfunction--a rationale for treatment with N-acetylcysteine.
Topics: Acetylcysteine; Cysteine; Cystine; Glutamates; Glutamic Acid; Glutathione; HIV; HIV Infections; Humans; Hydrogen Peroxide; Oxidation-Reduction; Oxygen; Palliative Care; Superoxides; T-Lymphocytes | 1992 |
Cellular antioxidant status and human immunodeficiency virus replication.
Topics: Acetylcysteine; Antioxidants; Cysteine; Glutathione; HIV; HIV Infections; Humans; Sulfhydryl Compounds; Virus Replication | 1992 |
Modulation of lymphocyte functions and immune responses by cysteine and cysteine derivatives.
Topics: Animals; Cysteine; Cystine; Gene Expression; HIV Infections; Humans; Lymphocytes; Models, Biological | 1991 |
7 trial(s) available for cysteine and HIV Coinfection
Article | Year |
---|---|
Comparative effects of acute-methionine loading on the plasma sulfur-amino acids in NAC-supplemented HIV+ patients and healthy controls.
Topics: Acetylcysteine; Adult; Antiretroviral Therapy, Highly Active; Cysteine; Dietary Supplements; Female; Glutathione; HIV Infections; HIV-1; Humans; Male; Methionine; Middle Aged | 2018 |
Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients.
Topics: Age Factors; Anti-HIV Agents; Body Composition; Cysteine; Dietary Supplements; Glutathione; Glycine; HIV Infections; HIV-1; Humans; Insulin Resistance; Male; Middle Aged; Mitochondria; Oxidation-Reduction | 2014 |
Effect of N-acetyl-L-cysteine on lymphocyte apoptosis, lymphocyte viability, TNF-alpha and IL-8 in HIV-infected patients undergoing anti-retroviral treatment.
Topics: Acetylcysteine; Administration, Oral; Adult; Anti-HIV Agents; Apoptosis; CD4 Lymphocyte Count; Cysteine; Double-Blind Method; Glutathione; HIV Infections; Humans; Interleukin-8; Lymphocytes; Middle Aged; Time Factors; Tumor Necrosis Factor-alpha; Viral Load | 2004 |
Effect of N-acetylcysteine(NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial.
Topics: Acetylcysteine; Adult; Aged; Antiviral Agents; CD4 Lymphocyte Count; Cysteine; Double-Blind Method; Female; Free Radical Scavengers; HIV Infections; HIV-1; Humans; Male; Middle Aged; Neutrophils; Nitroblue Tetrazolium; Superoxides; Tumor Necrosis Factor-alpha | 1996 |
Comparisons of oxidative metabolism and reductive capacity in sulfonamide-tolerant and -intolerant patients with human immunodeficiency virus.
Topics: Adult; Anti-Infective Agents; Caffeine; Cysteine; Drug Hypersensitivity; Female; HIV Infections; Humans; Male; Oxidation-Reduction; Phosphodiesterase Inhibitors; Pilot Projects; Prospective Studies; Sulfonamides; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virus.
Topics: Adult; Anti-HIV Agents; Cysteine; Dose-Response Relationship, Drug; Double-Blind Method; Glutathione; HIV Infections; Humans; Leukocytes, Mononuclear; Middle Aged; Prodrugs; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1998 |
Decrease of elevated N,N-dimethylglycine and N-methylglycine in human immunodeficiency virus infection during short-term highly active antiretroviral therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Antigens, CD; Antiretroviral Therapy, Highly Active; Biomarkers; Cystathionine; Cysteine; Fasting; Female; Folic Acid; HIV Infections; HIV-1; Homocysteine; Humans; Male; Methionine; Methylmalonic Acid; Middle Aged; Multivariate Analysis; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type II; Sarcosine; Vitamin B 6 | 2001 |
39 other study(ies) available for cysteine and HIV Coinfection
Article | Year |
---|---|
Gut dysbiosis and inflammatory blood markers precede HIV with limited changes after early seroconversion.
Topics: B-Cell Activating Factor; Bile Acids and Salts; Biomarkers; Cross-Sectional Studies; Cysteine; Dysbiosis; HIV Infections; Humans; Interleukin-8; Lipids; Lithocholic Acid; Serine; Seroconversion; Sphingosine; Sulfates; Tumor Necrosis Factor-alpha | 2022 |
Pharmacophore-Oriented Identification of Potential Leads as CCR5 Inhibitors to Block HIV Cellular Entry.
Topics: Cysteine; HIV; HIV Fusion Inhibitors; HIV Infections; Humans; Maraviroc; Molecular Docking Simulation; Molecular Dynamics Simulation; Pharmacophore; Receptors, CCR5; Receptors, Chemokine | 2022 |
Targeting redox heterogeneity to counteract drug tolerance in replicating
Topics: Acids; Animals; Antitubercular Agents; Bacterial Proteins; Chloroquine; Cysteine; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; HIV Infections; Macrophages; Mice, Inbred BALB C; Mycobacterium tuberculosis; Oxidation-Reduction; Phagosomes; Recurrence; RNA-Seq; Transcriptome; Tuberculosis | 2019 |
A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.
Topics: AIDS Vaccines; Antibodies, Neutralizing; Antibody Formation; Antibody Specificity; Cell Line; Cysteine; env Gene Products, Human Immunodeficiency Virus; Epitope Mapping; Epitopes; HEK293 Cells; High-Throughput Nucleotide Sequencing; HIV Antibodies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Immunization | 2020 |
TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use.
Topics: Autopsy; Biological Specimen Banks; Brain; Citric Acid Cycle; Cognitive Dysfunction; Cysteine; HIV Infections; HIV-1; Humans; Male; Methamphetamine; Middle Aged; Mitochondria; Neurons; Nitric Oxide; Protein Processing, Post-Translational; S-Nitrosothiols; Substance-Related Disorders; Synapses | 2021 |
Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Broadly Neutralizing Antibodies; Cohort Studies; Cysteine; Epitopes; Female; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Male; Middle Aged; Peptide Fragments; Phenotype; Phylogeny; Young Adult | 2019 |
Detection of drug bioactivation in vivo: mechanism of nevirapine-albumin conjugate formation in patients.
Topics: Adult; Aged; Anti-HIV Agents; Biotransformation; Cysteine; Glutathione S-Transferase pi; Histidine; HIV Infections; HIV-1; Humans; Middle Aged; Nevirapine; Protein Binding; Serum Albumin | 2013 |
Anti-retroviral therapy is associated with decreased alveolar glutathione levels even in healthy HIV-infected individuals.
Topics: Adult; Anti-Retroviral Agents; Body Mass Index; Bronchoalveolar Lavage; Case-Control Studies; Cohort Studies; Cross-Sectional Studies; Cysteine; Epithelium; Female; Glutathione; HIV Infections; Humans; Linear Models; Lung Diseases; Male; Middle Aged; Odds Ratio; Oxidation-Reduction; Oxidative Stress; Pulmonary Alveoli | 2014 |
Several N-Glycans on the HIV Envelope Glycoprotein gp120 Preferentially Locate Near Disulphide Bridges and Are Required for Efficient Infectivity and Virus Transmission.
Topics: Cell Adhesion Molecules; Conserved Sequence; Cysteine; Disulfides; Glycosylation; HEK293 Cells; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Lectins, C-Type; Models, Molecular; Mutagenesis, Site-Directed; Mutant Proteins; Mutation; Polysaccharides; Probability; Receptors, Cell Surface; Virion | 2015 |
Increasing glutathione concentrations with cysteine and glycine supplementation lowers inflammation in HIV patients.
Topics: C-Reactive Protein; Cysteine; Diet; Glutathione; Glycine; HIV Infections; Humans; Inflammation; Male; Middle Aged; Tumor Necrosis Factor-alpha | 2015 |
Low-Cost Method to Monitor Patient Adherence to HIV Antiretroviral Therapy Using Multiplex Cathepsin Zymography.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cathepsins; Cost-Benefit Analysis; Cysteine; Electrophoresis; Female; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Male; Medication Adherence; South Africa; Viral Load | 2016 |
Trimeric gp120-specific bovine monoclonal antibodies require cysteine and aromatic residues in CDRH3 for high affinity binding to HIV Env.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Cattle; Complementarity Determining Regions; Cysteine; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; Humans; Immunoglobulin Variable Region; Protein Engineering | 2017 |
Intramolecular interactions within the human immunodeficiency virus-1 gp41 loop region and their involvement in lipid merging.
Topics: Amino Acid Sequence; Cysteine; Disulfides; HIV Envelope Protein gp41; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Liposomes; Molecular Sequence Data; Oxidation-Reduction; Protein Multimerization; Protein Structure, Secondary; Spectrometry, Fluorescence; Virus Internalization | 2012 |
Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
Topics: Amino Acid Sequence; Cysteine; Enzyme-Linked Immunosorbent Assay; HIV Antibodies; HIV Antigens; HIV Envelope Protein gp120; HIV Envelope Protein gp41; HIV Infections; HIV-1; HIV-2; Human Immunodeficiency Virus Proteins; Humans; Molecular Sequence Data; Peptides; Reproducibility of Results; Sensitivity and Specificity | 2013 |
How HIV-1 causes AIDS: implications for prevention and treatment.
Topics: Acquired Immunodeficiency Syndrome; Cysteine; Glutamine; Glutathione; Glutathione Peroxidase; HIV Infections; HIV Seropositivity; HIV-1; Humans; Nutrition Disorders; Selenium; Tryptophan | 2004 |
Quantitation of reduced glutathione and cysteine in human immunodeficiency virus-infected patients.
Topics: CD4 Lymphocyte Count; Cysteine; Electrophoresis, Capillary; Erythrocytes; Glutathione; HIV; HIV Infections; Humans; RNA, Viral; Sulfhydryl Compounds; Viral Load; Viremia | 2004 |
Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection.
Topics: Adult; Anti-Infective Agents; Ascorbic Acid; Ascorbic Acid Deficiency; Case-Control Studies; CD4-CD8 Ratio; Cysteine; Dehydroascorbic Acid; Female; Glutathione; HIV Infections; Humans; In Vitro Techniques; Male; Middle Aged; Oxidation-Reduction; Sulfamethoxazole | 2004 |
HIV-1 Tat inhibits neprilysin and elevates amyloid beta.
Topics: Adult; Aging; AIDS Dementia Complex; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cell Membrane; Cells, Cultured; Cysteine; Frontal Lobe; Gene Products, tat; HIV Infections; HIV-1; Humans; Immunohistochemistry; Middle Aged; Neprilysin; tat Gene Products, Human Immunodeficiency Virus | 2005 |
Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.
Topics: Anti-HIV Agents; Cell Fusion; Circular Dichroism; Cysteine; Disulfides; Enfuvirtide; HIV Envelope Protein gp41; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Membrane Fusion; Neutralization Tests; Peptide Fragments; Protein Denaturation; Protein Structure, Quaternary; Recombinant Fusion Proteins; Structure-Activity Relationship; Temperature; Thermodynamics | 2005 |
Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
Topics: Arginine; Cell Line; Cell Line, Tumor; Cysteine; DNA Replication; Enzyme Activation; Gene Products, tat; HIV Infections; HIV-1; Humans; Molecular Structure; Neovascularization, Pathologic; NF-kappa B; Peptide Fragments; Receptors, CCR5; Recombinant Proteins; tat Gene Products, Human Immunodeficiency Virus | 2006 |
Modulation of transcription factor NF kappa B activity by intracellular glutathione levels and by variations of the extracellular cysteine supply.
Topics: Acetylcysteine; Animals; Base Sequence; Binding Sites; Cell Line; Cell Nucleus; Cysteine; Dithiothreitol; Dose-Response Relationship, Drug; Glutathione; Glutathione Disulfide; HIV; HIV Infections; Humans; Kinetics; Macaca mulatta; Molecular Sequence Data; NF-kappa B; Oligodeoxyribonucleotides; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Sulfhydryl Compounds; T-Lymphocytes; Transcriptional Activation | 1995 |
Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection.
Topics: CD4-Positive T-Lymphocytes; Cysteine; Glutamic Acid; Glutamine; Glutathione; HIV Infections; HIV-1; Humans; Interleukin-2; Lymphocyte Subsets; Oxidation-Reduction; Oxidative Stress; Tumor Necrosis Factor-alpha | 1995 |
Plasma amino acid dysregulation after lentiviral infection.
Topics: Amino Acids; Animals; Arthritis-Encephalitis Virus, Caprine; Chlorocebus aethiops; Cysteine; Cystine; Glutamates; Glutamic Acid; Goat Diseases; Goats; Hepatitis B; HIV Infections; HIV-1; Humans; Lentivirus Infections; Macaca mulatta; Pan troglodytes; Proline; Simian Acquired Immunodeficiency Syndrome | 1993 |
Oxidant-antioxidant status in human immunodeficiency virus infection.
Topics: Amino Acids; Antioxidants; Biomarkers; Cell Separation; Cells, Cultured; Culture Techniques; Cysteine; Cystine; Female; Glutamates; Glutamic Acid; Glutathione; HIV Infections; HIV Seropositivity; Humans; Indicators and Reagents; Lymphocytes; Male; Monocytes; Oxidants; Reference Values; Sex Characteristics; Spectrophotometry | 1994 |
The role of a cysteine and glutathione deficiency in the immunopathology of HIV infection.
Topics: CD4-Positive T-Lymphocytes; Cysteine; Glutathione; HIV Infections; Humans | 1994 |
Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection.
Topics: Adult; CD4 Lymphocyte Count; Cysteine; Dipeptides; Female; Folic Acid; HIV Antibodies; HIV Infections; HIV-1; Homocysteine; Humans; Interleukin-2; Lymphocytes; Male; Methionine; Middle Aged; Oxidation-Reduction; Oxidative Stress; Vitamin B 12 | 1996 |
Decreased release of glutathione into the systemic circulation of patients with HIV infection.
Topics: Adult; Amino Acid Sequence; Cysteine; Female; Glutathione; Glycine; HIV Infections; Humans; Lymphocytes; Male; Methionine; Middle Aged; Molecular Sequence Data; Taurine | 1996 |
Sequential change of cysteine residues in hypervariable region 1 of glycoprotein 120 in primary HIV type 1 isolates of subtype B.
Topics: Amino Acid Sequence; Cysteine; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Molecular Sequence Data; Sequence Alignment; Sequence Analysis | 1996 |
Oxidative stress and thiol depletion in plasma and peripheral blood lymphocytes from HIV-infected patients: toxicological and pathological implications.
Topics: Analysis of Variance; Cysteine; Disulfides; Drug Hypersensitivity; Glutathione; Glutathione Disulfide; HIV Infections; Humans; Leukocytes, Mononuclear; Oxidative Stress; Sulfonamides | 1997 |
A unique, naturally occurring single-amino acid mutation in HIV type 1 V3 loop can discriminate between its cytopathicity and replication in vivo and in vitro.
Topics: Amino Acid Sequence; Cysteine; Disease Progression; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Molecular Sequence Data; Mutation; Peptide Fragments; Virus Replication | 1998 |
Mitigation of hepato-cellular injury caused by HAART with glycyrrhizin compound in patients co-infected with HIV and HCV.
Topics: Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Cysteine; Drug Combinations; Drug Therapy, Combination; Glycine; Glycyrrhetinic Acid; Hemophilia A; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stavudine; Viral Load; Zalcitabine; Zidovudine | 1999 |
Plasma cysteine deficiency and decreased reduction of nitrososulfamethoxazole with HIV infection.
Topics: Adult; Chromatography, High Pressure Liquid; Cysteine; Disease Progression; Drug Hypersensitivity; HIV Infections; HIV-1; Humans; Middle Aged; Oxidation-Reduction; Sulfamethoxazole; Sulfhydryl Compounds | 2000 |
Replication of a pre-existing resistant HIV-1 subpopulation in vivo after introduction of a strong selective drug pressure.
Topics: Codon; Cysteine; Drug Resistance, Microbial; Follow-Up Studies; HIV Infections; HIV-1; Humans; Mutation; Nevirapine; Polymerase Chain Reaction; Proviruses; Reverse Transcriptase Inhibitors; RNA, Viral; Tyrosine; Viral Load | 1996 |
Free radicals, antioxidants and HIV.
Topics: Antioxidants; Cysteine; Free Radicals; Glutathione; HIV Infections; Humans | 1999 |
Erythrocytic glutathione and plasma cysteine status of human immunodeficient patients.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Chromatography, High Pressure Liquid; Cysteine; Electrochemistry; Erythrocytes; Female; Glutathione; Glutathione Disulfide; HIV Infections; Humans; Male; Middle Aged; Reproducibility of Results | 2001 |
Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Cysteine; Glutathione; HIV Infections; Humans; Leukocytes, Mononuclear; Male | 1992 |
Infection of Macaca nemestrina by human immunodeficiency virus type-1.
Topics: Animals; Base Sequence; CD4 Antigens; Cysteine; Databases, Factual; Genes, gag; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lymphocytes; Macaca nemestrina; Methionine; Molecular Sequence Data; Oligodeoxyribonucleotides; Oligonucleotide Probes; Viral Proteins; Virus Replication | 1992 |
Elevated plasma glutamate concentrations in HIV-1-infected patients may contribute to loss of macrophage and lymphocyte functions.
Topics: Cysteine; Glutamates; Glutamic Acid; HIV Infections; HIV-1; Humans; In Vitro Techniques; Lymphocyte Activation; Lymphocytes; Macrophages | 1989 |
Immunochemistry of the dominating antigenic region Ala582 to Cys604 in the transmembranous protein of simian and human immunodeficiency virus.
Topics: Alanine; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antigens, Surface; Binding, Competitive; Cross Reactions; Cysteine; HIV Antibodies; HIV Antigens; HIV Infections; Humans; Immunohistochemistry; Macaca mulatta; Membrane Proteins; Mice; Molecular Sequence Data; Peptides; Rabbits; Simian Immunodeficiency Virus | 1989 |